Scientists seeking to harness the power of the immune system to eradicate brain tumors face two major hurdles: recruiting key immune cells called dendritic cells into areas of the brain where they are not naturally found and helping them recognize tumor cells as targets for attack. Researchers at Cedars-Sinai Medical Center, however, have identified a
Full Post: Gene therapy kills brain tumors through selective recruitment of immune cells
In human relationships, a certain “spark” often governs whether we prefer one person more than another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell “friendships” operate in much the same way and that dysfunctional bonding is linked to the spread of cancer.
The research was published in the Nov. 18 early online edition of the Proceedings of the National Academies of Science and appears in the journal’s Nov. 25 print edition.
“Bonding between cells has important health implications,” said the study’s senior author, Denis Wirtz, a professor of chemical and biomolecular engineering in the Whiting School of Engineering at Johns Hopkins. “When cancer cells break free from their neighbors, they can spread the disease through the body. If we can learn more about this process, we may find new ways to keep cancer in check.”
Toward that goal, Wirtz, who also is associate director of the Johns Hopkins Institute for NanoBioTechnology, led a multi-institution team that focused on alpha-catenin, a small protein that floats in the cytoplasm, the gel-like material that surrounds the nucleus inside a cell. Alpha-catenin allows cells to recognize neighboring cells as “friends” in less than one millisecond, leading to the creation of many strong bonds that are hard to break. However, cancer cells, including those found in diffuse gastric cancer and lung cancer, possess dysfunctional alpha-catenin and form very weak bonds with their neighbors. This allows them to break free from cell masses and spread cancer throughout the body.
To better understand these bonding characteristics, Wirtz and his colleagues used a technique called atomic force microscopy to study single cells with and without functioning alpha-catenin. This technique records tiny forces, measured in nanoNewtons, that cells exert upon one another.
Wirtz’s team discovered that normal cells with properly functioning alpha-catenin formed bonds that were four times more stable than those without functional alpha-catenin, and these first bonds formed in less than one millisecond. The longer the cells remained in contact with one another, the more numerous and stronger these bonds became. The connections between these cells resembled those that occur with a popular type of fastener material. “This accelerated formation of additional bonds between neighboring cells was akin to the Velcro’ effect,” Wirtz said.
In contrast, cells without functional alpha-catenin formed weak bonds from the onset. Also, even as these cells remained in contact, bonding strengths continued to diminish. Wirtz suggested that if scientists could figure out a way to repair or replace the alpha-catenin dysfunction found in some cancer cells, it could lead to a therapy that thwarts the spread of cancer.
The research team members included Sean Sun, a Johns Hopkins associate professor of mechanical engineering; Saumendra Bajpai, a graduate student in the Johns Hopkins Department of Chemical and Biomolecular Engineering; Gianpaolo Suriano, Joana Figueiredo and Joana Correia, all affiliated with the Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; and Gregory Longmore and Yunfeung Feng of the departments of Medicine and Cell Biology, Washington University of St. Louis.
This work was supported by grants from the American Heart Association and the National Institutes of Health.
http://www.jhu.edu
--------------------------------------------------------------------------------------------
Related Posts:
In human relationships, a certain “spark” often governs whether we prefer one person to another, and critical first impressions can occur within seconds. A team lead by Johns Hopkins researchers has found that cell-to-cell “friendships” operate in much the same way and that dysfunctional bonding is linked to the spread of cancer. The research was
Full Post: Tiny protein provokes healthy bonding between cells
When researchers look inside human cancer cells for the whereabouts of an important tumor-suppressor, they often catch the protein playing hooky, lolling around in cellular broth instead of muscling its way out to the cells’ membranes and foiling cancer growth. This phenomenon of delinquency puzzled scientists for a long time - until a cell biologist
Full Post: Scientists genetically grab PTEN by the tail to curtail cancer
Two critical properties of cancer cells are their ability to divide without restraint and to spread away from the primary tumor to establish new tumor sites. Now, researchers from the Mayo Clinic campus in Florida have found a protein they say acts as a deadly master switch, both freeing cancer cells from a tumor while
Full Post: Scientists identify dangerous ‘two-faced’ protein crucial to breast cancer spread and growth
Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of
Full Post: Old Digitalis-based drugs show promise as a treatment for cancer
Taking a cue from the way drugs like Viagra put the biological brakes on a key enzyme involved in heart failure, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking the enzyme. The Johns Hopkins team reports how the enzyme, phosphodiesterase 5, or PDE5A, slows down the breakdown of another,
Full Post: Scientists map steps to block enzyme phosphodiesterase 5’s action in heart failure --------------------------------------------------------------------------------------------
